Sorption of selected antiparasitics in soils and sediments
Open Access
- 2 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Environmental Sciences Europe
- Vol. 33 (1), 1-15
- https://doi.org/10.1186/s12302-021-00513-y
Abstract
Background: Veterinary pharmaceuticals can enter the environment when excreted after application and burden terrestrial and aquatic ecosystems. However, knowledge about the basic process of sorption in soils and sediments is limited, complicating regulatory decisions. Therefore, batch equilibrium studies were conducted for the widely used antiparasitics abamectin, doramectin, ivermectin, and moxidectin to add to the assessment of their environmental fate. Results: We examined 20 soil samples and six sediments from Germany and Morocco. Analysis was based on HPLC-fluorescence detection after derivatization. For soils, this resulted in distribution coefficients KD of 38–642 mL/g for abamectin, doramectin, and ivermectin. Moxidectin displayed KD between 166 and 3123 mL/g. Normalized to soil organic carbon, log KOC coefficients were 3.63, 3.93, 4.12, and 4.74 mL/g, respectively, revealing high affinity to organic matter of soils and sediments. Within sediments, distribution resulted in higher log KOC of 4.03, 4.13, 4.61, and 4.97 mL/g for the four substances. This emphasizes the diverse nature of organic matter in both environmental media. The results also confirm a newly reported log KOW for ivermectin which is higher than longstanding assumptions. Linear sorption models facilitate comparison with other studies and help establish universal distribution coefficients for the environmental risk assessment of veterinary antiparasitics. Conclusions: Since environmental exposure affects soils and sediments, future sorption studies should aim to include both matrices to review these essential pharmaceuticals and mitigate environmental risks from their use. The addition of soils and sediments from the African continent (Morocco) touches upon possible broader applications of ivermectin for human use. Especially for ivermectin and moxidectin, strong sorption further indicates high hydrophobicity and provides initial concern for potential aquatic or terrestrial ecotoxicological effects such as bioaccumulation. Our derived KOW estimates also urge to re-assess this important regulatory parameter with contemporary techniques for all four substances. GraphicKeywords
Funding Information
- Bundesministerium für Bildung und Forschung (01DH17038)
- Justus-Liebig-Universität Gießen
This publication has 73 references indexed in Scilit:
- Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for eliminationMalaria Journal, 2013
- An inconvenient truth: Global worming and anthelmintic resistanceVeterinary Parasitology, 2012
- Ivermectin, 'Wonder drug' from Japan: the human use perspectiveProceedings of the Japan Academy, Series B, 2011
- Environmental risk assessment of ivermectin: A case studyIntegrated Environmental Assessment and Management, 2010
- Molecular size cutoff criteria for screening bioaccumulation potential: Fact or fiction?Integrated Environmental Assessment and Management, 2010
- Assessment of the environmental fate and effects of ivermectin in aquatic mesocosmsAquatic Toxicology, 2007
- Estimating organic carbon in the soils of Europe for policy supportEuropean Journal of Soil Science, 2005
- The changing landscape of antiparasitic drug discovery for veterinary medicineTrends in Parasitology, 2004
- Concentration of 22,23-dihydroavermectin B1a detected in the sediments at an Atlantic salmon farm using orally administered ivermectin to control sea-lice infestationAquaculture, 2000
- Environmental risk of ivermectin to sediment dwelling organismsAquaculture, 1998